Mary Ann Liebert: Pregnant, Lactating Women With COVID-19-Scant Clinical Research
May 19, 2020
May 19, 2020
NEW ROCHELLE, New York, May 19 -- Mary Ann Liebert Inc. issued the following news release:
Pregnant and breastfeeding women have been excluded from clinical trials of drugs to treat COVID-19, and as result, there is no safety data to inform clinical decisions. Such drugs include remdesivir according to a new article in the peer-reviewed journal Breastfeeding Medicine. Click here (http://email.liebertpub.com/c/112gM9Phd6tAKFGW5SRmMs) to read the article.
Since pregnant a . . .
Pregnant and breastfeeding women have been excluded from clinical trials of drugs to treat COVID-19, and as result, there is no safety data to inform clinical decisions. Such drugs include remdesivir according to a new article in the peer-reviewed journal Breastfeeding Medicine. Click here (http://email.liebertpub.com/c/112gM9Phd6tAKFGW5SRmMs) to read the article.
Since pregnant a . . .